Cardiol Therapeutics Inc.

NASDAQ: CRDL · Real-Time Price · USD
1.32
-0.02 (-1.49%)
At close: Aug 15, 2025, 2:44 PM

Cardiol Therapeutics Cash Flow Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-35.79M -36.68M -36.14M -29.34M -30.22M -28.13M -28.01M -30.05M -29.07M -30.93M -29.67M -31.61M -31.68M -31.64M -35.05M -29.54M -26.6M
Depreciation & Amortization
336.48K 373.11K 391.38K 255.19K 251.77K 248.35K 239.63K 229.21K 224.49K 219.91K 217.46K 218.58K 219.42K 220.42K 223.22K 224.98K 227.81K
Stock-Based Compensation
12.72M 12.47M 9.33M 2.96M 3.62M 3.15M 4.09M 5.62M 4.37M 5.01M 8.65M 6.01M 7.42M 8.5M 4.23M 3.91M 4.16M
Other Working Capital
-1.75M -2.39M -2.8M -318.62K 1.05M -1.44M -122.06K 1.04M 2.5M 5.89M 5.28M 4.82M 1.14M 107.16K 4.44M 4.66M 6.57M
Other Non-Cash Items
-727.3K 733.96K 1.18M 2.17M 422.97K -1.13M 118.87K 331.55K 1.04M 1.89M -1.99M -228.3K -505.42K -707.31K 3.12M 1.18M 752.28K
Deferred Income Tax
n/a n/a n/a 575.32K 585.68K 508.84K -3.93M -6.23M -7.11M -9.16M -9.63M -7.91M -7.05M -4.92M n/a n/a n/a
Change in Working Capital
-1.83M -1.71M -1.17M 1.33M 2.71M -545.88K -145.94K 978.36K 2.39M 5.75M 5.2M 4.81M 1.18M 76.52K 5.33M 5.49M 7.62M
Operating Cash Flow
-25.29M -25.06M -25.93M -21.58M -22.16M -25.18M -27.64M -29.12M -28.14M -27.22M -22.31M -23.79M -25.49M -23.55M -22.13M -18.73M -13.84M
Capital Expenditures
-29.77K -21.29K -25.84K -23.54K -23.63K -64.31K -101.44K -105.15K -103.38K -74.71K -26.88K -30.51K -28.38K -12.92K -26.41K -20.5K -22.55K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-29.77K -21.29K -25.84K -23.54K -23.63K -64.31K -101.44K -105.15K -103.38K -74.71K -26.88K -30.51K -28.38K -12.92K -26.41K -20.5K -22.55K
Debt Repayment
-41.53K -41.53K -41.53K -50.76K -55.38K -55.38K -55.38K -55.38K -54.8K -53.93K -53.07K -52.2K -51.92K -51.92K -51.91K -51.91K -51.34K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
18.79M 18.88M 177.51K 177.51K 90.2K -0.00 -0.00 -0.00 -0.00 -0.00 -2.81M -468.72K 20.33M 31.41M 34.32M 32.09M 10.17M
Financial Cash Flow
18.75M 18.84M 135.98K 126.75K 34.82K -55.38K -55.38K -55.38K -54.8K -53.93K 59.21M 61.56M 82.36M 93.44M 34.26M 32.03M 27.37M
Net Cash Flow
-5.28M -4.29M -24.59M -20.86M -20.83M -24.54M -24.99M -25.51M -25.38M -24.43M 36.88M 37.73M 56.84M 69.87M 12.11M 13.29M 13.51M
Free Cash Flow
-25.32M -25.08M -25.96M -21.6M -22.18M -25.24M -27.74M -29.23M -28.24M -27.3M -22.33M -23.82M -25.52M -23.56M -22.16M -18.75M -13.86M